A detailed history of Charles Schwab Investment Management Inc transactions in Geron Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 4,450,382 shares of GERN stock, worth $16.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,450,382
Previous 4,339,021 2.57%
Holding current value
$16.3 Million
Previous $18.4 Million 9.82%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.17 - $4.99 $464,375 - $555,691
111,361 Added 2.57%
4,450,382 $20.2 Million
Q2 2024

Aug 12, 2024

BUY
$3.1 - $5.09 $1.39 Million - $2.29 Million
449,265 Added 11.55%
4,339,021 $18.4 Million
Q1 2024

May 08, 2024

BUY
$1.75 - $3.44 $82,698 - $162,560
47,256 Added 1.23%
3,889,756 $12.8 Million
Q4 2023

Feb 06, 2024

BUY
$1.74 - $2.31 $362,215 - $480,872
208,170 Added 5.73%
3,842,500 $8.11 Million
Q3 2023

Nov 08, 2023

BUY
$2.11 - $3.28 $4.85 Million - $7.54 Million
2,300,220 Added 172.42%
3,634,330 $7.7 Million
Q2 2023

Aug 09, 2023

BUY
$1.97 - $3.69 $385,316 - $721,734
195,592 Added 17.18%
1,334,110 $4.28 Million
Q1 2023

May 11, 2023

BUY
$2.14 - $3.4 $379,597 - $603,098
177,382 Added 18.46%
1,138,518 $2.47 Million
Q4 2022

Feb 13, 2023

BUY
$2.03 - $2.42 $58,472 - $69,705
28,804 Added 3.09%
961,136 $2.33 Million
Q3 2022

Nov 14, 2022

SELL
$1.67 - $2.94 $48,680 - $85,701
-29,150 Reduced 3.03%
932,332 $2.18 Million
Q2 2022

Aug 15, 2022

BUY
$1.19 - $1.65 $130,904 - $181,506
110,004 Added 12.92%
961,482 $1.49 Million
Q1 2022

May 13, 2022

BUY
$0.99 - $1.6 $73,732 - $119,163
74,477 Added 9.59%
851,478 $1.16 Million
Q4 2021

Feb 11, 2022

BUY
$1.22 - $1.72 $4,894 - $6,900
4,012 Added 0.52%
777,001 $948,000
Q3 2021

Nov 16, 2021

SELL
$1.2 - $1.5 $1.69 Million - $2.11 Million
-1,408,234 Reduced 64.56%
772,989 $1.06 Million
Q2 2021

Aug 16, 2021

BUY
$1.25 - $1.83 $144,316 - $211,278
115,453 Added 5.59%
2,181,223 $3.08 Million
Q1 2021

May 17, 2021

BUY
$1.52 - $2.1 $77,965 - $107,715
51,293 Added 2.55%
2,065,770 $3.26 Million
Q4 2020

Feb 16, 2021

BUY
$1.55 - $2.05 $4,473 - $5,916
2,886 Added 0.14%
2,014,477 $3.2 Million
Q3 2020

Nov 13, 2020

BUY
$1.59 - $2.19 $324,914 - $447,524
204,349 Added 11.31%
2,011,591 $3.5 Million
Q2 2020

Aug 14, 2020

BUY
$1.05 - $2.18 $627,168 - $1.3 Million
597,303 Added 49.37%
1,807,242 $3.94 Million
Q1 2020

May 15, 2020

BUY
$0.89 - $1.49 $16,603 - $27,797
18,656 Added 1.57%
1,209,939 $1.44 Million
Q4 2019

Feb 07, 2020

BUY
$1.27 - $1.54 $109,090 - $132,282
85,898 Added 7.77%
1,191,283 $1.62 Million
Q3 2019

Nov 08, 2019

BUY
$1.15 - $1.59 $28,476 - $39,371
24,762 Added 2.29%
1,105,385 $1.47 Million
Q2 2019

Aug 09, 2019

BUY
$1.37 - $2.02 $43,083 - $63,524
31,448 Added 3.0%
1,080,623 $1.52 Million
Q1 2019

May 14, 2019

BUY
$1.01 - $1.83 $172,404 - $312,377
170,698 Added 19.43%
1,049,175 $1.74 Million
Q4 2018

Feb 14, 2019

SELL
$0.98 - $1.85 $105,891 - $199,898
-108,053 Reduced 10.95%
878,477 $879,000
Q3 2018

Nov 13, 2018

BUY
$1.76 - $6.38 $1.13 Million - $4.11 Million
643,530 Added 187.62%
986,530 $1.74 Million
Q2 2018

Aug 08, 2018

BUY
$3.29 - $4.82 $163,184 - $239,072
49,600 Added 16.91%
343,000 $1.18 Million
Q3 2017

Nov 13, 2017

BUY
$1.99 - $2.65 $583,866 - $777,510
293,400
293,400 $640,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.38B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.